Currently browsing category

Statins

Am-I-at-Risk

RISK REDUCTIONS IN CLINICAL TRIALS

  ~by Dr. Neville Wilson.     WHAT DO WE MEAN BY REDUCING THE RISK OF A DISEASE ?   In the provision of Healthcare, RISK refers to the probability of a bad outcome for a person who has a disease, where the “bad outcome” might be a non-fatal heart attack …

Anatomy of the Thyroid and Parathyroid Glands

HYPOTHYROIDISM – DETECTION, DIAGNOSIS & TREATMENT

Dr. Neville Wilson 15 January 2015   Multitudes of people wake up every day experiencing a wide range of chronic and debilitating systems without the realization that their unrelenting complaints may be the direct cause of an undetected and untreated underactive thyroid gland. The thyroid gland is a small “shield …

Himalayan Salt

SALT INTAKE – HARMFUL OR HEALTHY ?

Dr. Neville Wilson, 20 August, 2014. Public health messages, throughout the Western world, are vocal about the dangers of excess salt in the diet, warning of increased risks for high blood pressure, cardiovascular disease, heart failure and premature death. The United States Department of Agriculture (USDA) declares that salt is …

unnecessary medication

NEW CARDIOVASCULAR GUIDELINES 2013.

The American Heart Association (AHA) and American College of Cardiology (ACC) have released their 2013 Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.  The new Guidelines have not been without controversy, and include welcome revisions of previous guidelines, but add confusion by introducing a …

Obese and Smoking

DO STATINS BENEFIT HEALTHY PEOPLE ?

  by  Dr. Neville Wilson.    ( MODERN MEDICINE Vol 43, Number 2, 2013 – The Irish Journal of Clinical Medicine)   Statins are inhibitors of the enzyme (HMG-CoA) reductase, which catalyses the rate limiting step in cholesterol formation, reducing total and low-density lipoprotein (LDL) cholesterol concentrations, but also inhibiting …

Tredaptive

THE RISE AND FALL OF TREDAPTIVE

by Dr. Neville Wilson 30 Jan 2013   Tredaptive was introduced into the European drug market on 3rd July 2008, as a pharmaceutical formulation designed to treat certain forms of mixed  dyslipidaemia in patients judged to be at risk of cardiovascular disease. On the basis of well established cardiovascular benefits of …

Statins and Mortality

Dr. Neville S. Wilson. – 15 July 2007. The widely held belief that blood cholesterol levels are potentially harmful and should be lowered in order to prevent heart disease is a product of speculative and persuasive promotion by advocates of what has been called the “cholesterol hypothesis“. The pharmaceutical industry …